ym 09151-2 has been researched along with alprostadil in 1 studies
| Studies (ym 09151-2) | Trials (ym 09151-2) | Recent Studies (post-2010) (ym 09151-2) | Studies (alprostadil) | Trials (alprostadil) | Recent Studies (post-2010) (alprostadil) |
|---|---|---|---|---|---|
| 249 | 6 | 13 | 7,136 | 864 | 761 |
| Protein | Taxonomy | ym 09151-2 (IC50) | alprostadil (IC50) |
|---|---|---|---|
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | 2.3 | |
| Solute carrier organic anion transporter family member 2B1 | Rattus norvegicus (Norway rat) | 0.0358 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chihara, K; Fujita, T; Iwasaki, J; Kaji, H; Kodama, H; Matsumoto, S; Minamitani, N; Shirataki, K; Tamaki, N | 1 |
1 other study(ies) available for ym 09151-2 and alprostadil
| Article | Year |
|---|---|
Prolactin secretion from human prolactinomas perifused in vitro: effect of TRH, prostaglandin E1, theophylline, dopamine and dopamine receptor blockers.
Topics: Adult; Alprostadil; Benzamides; Dopamine; Female; Humans; Male; Perfusion; Pituitary Neoplasms; Prolactin; Prostaglandins E; Receptors, Dopamine; Sulpiride; Theophylline; Thyrotropin-Releasing Hormone | 1984 |